Logo

Illumina to Raise $30.7M in Common Stock Offering

May 11, 2004

NEW YORK, May 11 (GenomeWeb News) - Illumina will raise approximately $30.7 million in a common stock offering, the company said today.

 

Illumina will sell approximately 4.5 million shares of its common stock at $6.75 per share to a group of institutional investors.

 

The company said it has obtained commitments to purchase $30.7 million of its common stock and expects to close the offering on May 14.

Breaking News
The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.